Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
Top Cited Papers
- 1 August 2010
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Vol. 23 (4), 243-252
- https://doi.org/10.1089/jamp.2009.0775
Abstract
Acute lung injury (ALI) remains a significant source of morbidity and mortality in the critically ill patient population. Defined by a constellation of clinical criteria (acute onset of bilateral pulmonary infiltrates with hypoxemia without evidence of hydrostatic pulmonary edema), ALI has a high incidence (200,000 per year in the US) and overall mortality remains high. Pathogenesis of ALI is explained by injury to both the vascular endothelium and alveolar epithelium. Recent advances in the understanding of pathophysiology have identified several biologic markers that are associated with worse clinical outcomes. Phase III clinical trials by the NHLBI ARDS Network have resulted in improvement in survival and a reduction in the duration of mechanical ventilation with a lung-protective ventilation strategy and fluid conservative protocol. Potential areas of future treatments include nutritional strategies, statin therapy, and mesenchymal stem cells.Keywords
This publication has 102 references indexed in Scilit:
- Transepithelial Migration of NeutrophilsAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Recent trends in acute lung injury mortality: 1996–2005*Critical Care Medicine, 2009
- Racial and ethnic disparities in mortality from acute lung injury*Critical Care Medicine, 2009
- Predictors of mortality in acute lung injury during the era of lung protective ventilationThorax, 2008
- Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injuryIntensive Care Medicine, 2008
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injuryThorax, 2008
- Acute Lung Injury Edema Fluid Decreases Net Fluid Transport across Human Alveolar Epithelial Type II CellsOnline Journal of Public Health Informatics, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation*Pediatric Critical Care Medicine, 2007
- From evidence to clinical practice: Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest*Critical Care Medicine, 2006